导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.19% | 657/1050 |
| 近一周 | -3.74% | 932/1104 |
| 近一月 | -6.50% | 760/1102 |
| 近一季 | -17.28% | 906/1092 |
| 近半年 | -13.52% | 853/1070 |
| 近一年 | 4.79% | 476/1018 |
| 近两年 | 85.24% | 248/926 |
| 近三年 | 13.76% | 561/834 |
| 成立以来 | 77.45% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.99% 198/1070 |
20.48% 380/1101 |
- - |
- - |
| 2025 | 54.53% 151/1065 |
3.15% 535/1014 |
3.10% 428/1038 |
44.76% 129/1050 |
0.38% 433/1065 |
| 2024 | -2.22% 640/1011 |
-7.84% 691/960 |
-3.23% 523/983 |
24.57% 18/991 |
-11.99% 957/1011 |
| 2023 | -21.41% 701/952 |
1.27% 554/880 |
-0.84% 232/895 |
-3.07% 205/915 |
-19.26% 913/952 |
| 2022 | -17.83% 249/867 |
-2.92% 16/773 |
-4.35% 754/806 |
-12.27% 408/845 |
0.87% 393/867 |
| 2021 | 22.43% 140/740 |
-9.91% 489/580 |
9.25% 379/659 |
20.25% 17/704 |
3.45% 280/740 |
| 2020 | 32.77% 338/554 |
-1.68% 206/419 |
14.70% 358/466 |
3.68% 378/517 |
13.56% 238/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银产业升级股票A VS. 东吴新产业精选股票A(580008) |